BJCT-BIOJECT-needle less injection product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: James Strauss who wrote (212)	7/21/1998 8:31:00 PM
From: Marc Kahn	Read Replies (3) of 534

I heard an interesting tid-bit today. This falls under the "rumor" category, but considering where it came from, I believe that it is true. Apparently the sales rep devoted to pursuing the US military is doing a good job. Bioject has received an order for more than 100,000 Biojector ampules for the military. We are currently in the 2nd quarter, which has historically been our best quarter for product sales, because of flu shot season. With additional orders such as this one, we could be headed for a very good "revenue from product sales" number for Q2. Add in the $1.5 million up-front payment from Merck, and I don't think a person would be too far out of line predicting a PROFITABLE quarter. Wouldn't that feel good? Marc Kahn

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next